Nov 16, 2020 / 03:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - Analyst
All right. Good morning, everybody, on this first day at the Stephens conference. I'm Jacob Johnson, the life science tools and diagnostics analyst here at Stephens. Really excited to be joined this morning by Catalent. We have CFO, Wetteny Joseph; and VP of IR, Paul Surdez. (Operator Instructions)
Let me, maybe to kick things off, if you'd just like to spend a few minutes with some opening comments, certainly no shortage of positive developments at Catalent over the last year or so.
Wetteny N. Joseph - Catalent, Inc. - Senior VP & CFO
Thank you, Jacob. I appreciate it. As we may make some forward-looking statements today. I'd like to refer you to our SEC filings to understand the risks and uncertainties that may bear on our operating results and financial condition. Let me just give a quick summary, given our -- we've completed our first quarter, and just remind everyone that our top priority during the COVID-19 pandemic continues to be keeping our employees safe. And in doing so, we're
Catalent Inc at Stephens NASH Investment Conference (Virtual) Transcript
Nov 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers